|
Volumn 19, Issue 6, 2001, Pages 573-580
|
Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine
a b c c |
Author keywords
Acquired immunodeficiency syndrome (AIDS); Bleomycin; Doxorubicin; Health related quality of life; Kaposi's sarcoma; Pegylated liposomal doxorubicin; Vincristine
|
Indexed keywords
BLEOMYCIN;
DOXORUBICIN;
LIPOSOME;
VINCRISTINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DRUG FORMULATION;
FEMALE;
HUMAN;
KAPOSI SARCOMA;
MAJOR CLINICAL STUDY;
MALE;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
DOXORUBICIN;
DRUG CARRIERS;
HEALTH STATUS;
HUMANS;
LIPOSOMES;
MALE;
QUALITY OF LIFE;
SARCOMA, KAPOSI;
TIME FACTORS;
VINCRISTINE;
|
EID: 0034924045
PISSN: 07357907
EISSN: None
Source Type: Journal
DOI: 10.1081/CNV-100104284 Document Type: Article |
Times cited : (39)
|
References (20)
|